• Most Popular
  • Most Shared

UPDATE 1-XenoPort, Arena shares fall on discounted stock offer

Wed Jul 8, 2009 11:07am EDT

Stocks

   

* XenoPort's 2.5 mln shr offering priced at $19/shr

Stocks

* Arena's 12.5 mln shr offering priced at $4.17/shr

* XenoPort, Arena shares down more than 11 pct

July 8 (Reuters) - Shares of U.S. drugmakers XenoPort Inc (XNPT.O) and Arena Pharmaceuticals Inc (ARNA.O) fell more than 11 percent on Wednesday, after their public offering of shares was priced below their Tuesday close.

XenoPort, a biopharmaceutical company that is developing drugs for migraine headaches, neuropathic pain and restless leg syndrome among others, said it is offering 2.5 million common shares at $19 a share.

XenoPort shares closed at $21.50 Tuesday on Nasdaq. They fell to $18.87 in Wednesday morning trade.

Arena, which is seeking U.S. regulatory approval for its experimental obesity drug Lorcaserin, said it is offering 12.5 million common shares at $4.17 apiece. It expects gross proceeds of about $52.1 million.

Shares of Arena fell to $4.08 in morning trade Wednesday. They closed at $4.67 Tuesday on Nasdaq.

For the alerts, please click [ID:nWNAB5291] [ID:nWNAB5295] (Reporting by Esha Dey in Bangalore; Editing by Ratul Ray Chaudhuri)



More from Reuters

Photo

Accused 9/11 plotters may face NY "Guantanamo"

NEW YORK (Reuters) - If the men accused of plotting the September 11 attacks wonder what conditions they might face when they are moved to New York from Guantanamo Bay for trial, they can expect solitary confinement, 23-hour-a-day lockdowns, constant video surveillance and almost no visitors.

 A broker waits for a phone call as he trades on the dealing floor at ICAP in Jersey City, New Jersey December 9, 2009. REUTERS/Lucas Jackson

Easy come, easy go

After a run of easy money this year, fund managers cast a wary eye on investment prospects in 2010.  Full Article 

"I don't think this is the bottom. We're going to have more problems in the world economy. We're papering over the problems more than anything else."

Well-known investorJim Rogers,
on the sinking greenback and the fundamental problems with the U.S. economy